404838006: Atazanavir sulfate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Protease inhibitor\Atazanavir sulfate (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Atazanavir sulfate (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Protease inhibitor\Atazanavir sulfate (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Atazanavir sulfate (substance)

\Organic compound\Organic nitrogen compound\Atazanavir sulfate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2148668018 Atazanavir sulfate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2153892018 Atazanavir sulphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

2154915012 Atazanavir sulfate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

15151000188116 Atazanavir sulfate fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Atazanavir sulfate (substance)	Is a	Protease inhibitor	true	Inferred relationship	Some
Atazanavir sulfate (substance)	Is a	allergène médicamenteux	false	Inferred relationship	Some
Atazanavir sulfate (substance)	Is a	Atazanavir (substance)	false	Inferred relationship	Some
Atazanavir sulfate (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Protease inhibitor (disposition)	true	Inferred relationship	Some
Atazanavir sulfate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Atazanavir (substance)	true	Inferred relationship	Some
Atazanavir sulfate (substance)	Is a	Organic nitrogen compound	true	Inferred relationship	Some
Atazanavir sulfate (substance)	Is a	Substance with effector mechanism of action (substance)	false	Inferred relationship	Some
Atazanavir sulfate (substance)	Is a	Anti-infective agent (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Atazanavir sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atazanavir sulfate (substance)	Inferred relationship	Some
Atazanavir sulfate 100mg capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atazanavir sulfate (substance)	Inferred relationship	Some
Atazanavir sulfate 150mg capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atazanavir sulfate (substance)	Inferred relationship	Some
Atazanavir sulfate 200mg capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atazanavir sulfate (substance)	Inferred relationship	Some
Reyataz 200mg capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atazanavir sulfate (substance)	Inferred relationship	Some
Reyataz 150mg capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atazanavir sulfate (substance)	Inferred relationship	Some
Reyataz 100mg capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atazanavir sulfate (substance)	Inferred relationship	Some
Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atazanavir sulfate (substance)	Inferred relationship	Some
Atazanavir (as atazanavir sulfate) 100 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atazanavir sulfate (substance)	Inferred relationship	Some
Atazanavir (as atazanavir sulfate) 150 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atazanavir sulfate (substance)	Inferred relationship	Some
Product containing precisely atazanavir (as atazanavir sulfate) 200 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atazanavir sulfate (substance)	Inferred relationship	Some
Atazanavir (as atazanavir sulfate) 100 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atazanavir sulfate (substance)	Inferred relationship	Some	1
Atazanavir (as atazanavir sulfate) 150 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atazanavir sulfate (substance)	Inferred relationship	Some	1
Product containing precisely atazanavir (as atazanavir sulfate) 200 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atazanavir sulfate (substance)	Inferred relationship	Some	1
Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atazanavir sulfate (substance)	Inferred relationship	Some	1
Atazanavir (as atazanavir sulfate) 100 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Atazanavir sulfate (substance)	Inferred relationship	Some	1
Atazanavir (as atazanavir sulfate) 150 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Atazanavir sulfate (substance)	Inferred relationship	Some	1
Product containing precisely atazanavir (as atazanavir sulfate) 200 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Atazanavir sulfate (substance)	Inferred relationship	Some	1
Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Atazanavir sulfate (substance)	Inferred relationship	Some	1
Atazanavir (as atazanavir sulfate) 300 mg and ritonavir 100 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Atazanavir sulfate (substance)	Inferred relationship	Some	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2148668018	Atazanavir sulfate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2153892018	Atazanavir sulphate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2154915012	Atazanavir sulfate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
15151000188116	Atazanavir sulfate	fr	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module